Rinvoq (upadacitinib) is not classified as a biologic. It is a Janus kinase (JAK) inhibitor, which works by inhibiting chemicals involved in signaling the immune system to attack the tissues. This is different from biologics, which are typically protein-based therapies targeting specific components of the immune system.

I Show Full Answer

Rinvoq (upadacitinib) is not classified as a biologic. It is a Janus kinase (JAK) inhibitor, which works by inhibiting chemicals involved in signaling the immune system to attack the tissues. This is different from biologics, which are typically protein-based therapies targeting specific components of the immune system.

If Rinvoq is working well for your Psoriatic Arthritis (PsA), that's great to hear! Always consult with your healthcare provider for personalized advice and treatment options.

 This AI-generated response comes from MyPsoriasisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Rinvoq (Upadacitinib) for Psoriasis | MyPsoriasisTeam

FDA Approves Rinvoq for Active Psoriatic Arthritis | MyPsoriasisTeam